Clinical Trials Directory

Trials / Unknown

UnknownNCT01672203

Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Incidence in Patients With Central Versus Peripheral Embolism

Incidence of CTEPH in Dependence of Thrombus Location in Patients With Acute Pulmonary Embolism and Index Fibrinolysis

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
University of Cologne · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Chronic thromboembolic pulmonary hypertension (CTEPH) has been associated with increased morbidity and mortality. Patients with pulmonary embolism (PE) have elevated risk for development of CTEPH. It is not known, whether the location of pulmonary embolism (central vs. peripheral) nor fibrinolysis have an impact of CTEPH incidence. This study has been performed to assess the CTEPH incidence in different populations: in patients with central vs. peripheral PE and in patients with or without fibrinolysis therapy for PE.

Detailed description

The embolus localization during index pulmonary embolism might be of potential relevance for CTEPH development. In the present study patients with confirmed pulmonary embolism for at least 12 months will be screened for CTEPH. The incidence of CTEPH will be correlated to thrombus location (central vs. peripheral) and the index use of fibrinolysis.

Conditions

Timeline

Start date
2009-01-01
Primary completion
2012-10-01
Completion
2012-11-01
First posted
2012-08-24
Last updated
2012-08-24

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01672203. Inclusion in this directory is not an endorsement.